UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Poor reception?

The Lancet (British edition), 2009-09, Vol.374 (9693), p.948-948

2009

Link zum Volltext

Verfügbarkeit prüfen

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

Nature (London), 2012-01, Vol.481 (7381), p.389-393

2012

Link zum Volltext

Verfügbarkeit prüfen

Velamentous insertion of the umbilical cord of twin B as a cause of vasa previa in monochorionic diamniotic twins

International journal of gynecology and obstetrics, 2013-09, Vol.122 (3), p.261-262

2013

Link zum Volltext

Verfügbarkeit prüfen

SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer

Clinical cancer research, 2016-01, Vol.22 (2), p.479-491

2016

Link zum Volltext

Verfügbarkeit prüfen

FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer

International journal of oncology, 2009-07, Vol.35 (1), p.57-68

2009

Link zum Volltext

Verfügbarkeit prüfen

The role of SRC-3 in human breast cancer

Nature reviews. Clinical oncology, 2010-02, Vol.7 (2), p.83-89

2010

Link zum Volltext

Verfügbarkeit prüfen

The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease

European journal of surgical oncology, 2010-03, Vol.36 (3), p.224-229

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-15-05: Effects on outcome of concomitant neoadjuvant chemotherapy-trastuzumab compared with sequential neoadjuvant chemotherapy followed by post-operative trastuzumab

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P4-P4-15-05

2015

Link zum Volltext

Verfügbarkeit prüfen

Does ER-βcx Really Have No Clinical Importance in Tamoxifen-Treated Breast Cancer Patients?

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5824-5824

2008

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer

Oncotarget, 2016-03, Vol.7 (11), p.13209-13220

2016

Link zum Volltext

Verfügbarkeit prüfen

An unusual triple-negative breast carcinoma

Histopathology, 2009-09, Vol.55 (3), p.364-366

2009

Link zum Volltext

Verfügbarkeit prüfen

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.(Letter to the editor)

Nature (London), 2012-01, Vol.481 (7381), p.389

2012

Link zum Volltext

Verfügbarkeit prüfen

Guided tissue regeneration, barrier membranes and reconstruction of the cleft maxillary alveolus

The Journal of craniofacial surgery, 2006-11, Vol.17 (6), p.1153-1160

2006

Link zum Volltext

Verfügbarkeit prüfen

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome

Clinical breast cancer, 2011-06, Vol.11 (3), p.153-160

2011

Link zum Volltext

Verfügbarkeit prüfen

Correction: The role of SRC-3 in human breast cancer

Nature reviews. Clinical oncology, 2010-03, Vol.7 (3), p.122-122

2010

Link zum Volltext

Verfügbarkeit prüfen

The role of SRC-3 in human breast cancer

Nature reviews. Clinical oncology, 2010-03, Vol.7 (3), p.122-122

2010

Link zum Volltext

Verfügbarkeit prüfen

Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era

Clinical breast cancer, 2011-04, Vol.11 (2), p.93-102

2011

Link zum Volltext

Verfügbarkeit prüfen

Expression of selected proteins in breast cancer brain metastases

Folia histochemica et cytobiologica, 2013-01, Vol.51 (3), p.213-218

2013

Link zum Volltext

Verfügbarkeit prüfen

Does ER-betacx really have no clinical importance in tamoxifen-treated breast cancer patients?

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5824; author reply 5825-5824; author reply 5826

2008

Link zum Volltext

Verfügbarkeit prüfen

An unusual triple-negative breast carcinoma

Histopathology, 2009, Vol.55 (3), p.364-366

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(19)
Berichte
(1)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Humans
(14)
Life Sciences & Biomedicine
(14)
Female
(13)
Oncology
(9)
Breast Cancer
(7)
Middle Aged
(7)
Treatment Outcome
(6)
Breast Neoplasms - Drug Therapy
(5)
Breast Neoplasms - Genetics
(5)
Prognosis
(5)
Adult
(4)
Aged
(4)
Animals
(4)
Breast Neoplasms - Diagnosis
(4)
Gene Expression Regulation, Neoplastic
(4)
Nuclear Receptor Coactivator 3 - Metabolism
(4)
Biological And Medical Sciences
(3)
Biomarkers, Tumor - Metabolism
(3)
Breast Neoplasms - Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Poor reception?

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

Velamentous insertion of the umbilical cord of twin B as a cause of vasa previa in monochorionic diamniotic twins

SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer

FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer

The role of SRC-3 in human breast cancer

The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease

Abstract P4-15-05: Effects on outcome of concomitant neoadjuvant chemotherapy-trastuzumab compared with sequential neoadjuvant chemotherapy followed by post-operative trastuzumab

Does ER-βcx Really Have No Clinical Importance in Tamoxifen-Treated Breast Cancer Patients?

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer

An unusual triple-negative breast carcinoma

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.(Letter to the editor)

Guided tissue regeneration, barrier membranes and reconstruction of the cleft maxillary alveolus

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome

Correction: The role of SRC-3 in human breast cancer

The role of SRC-3 in human breast cancer

Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era

Expression of selected proteins in breast cancer brain metastases

Does ER-betacx really have no clinical importance in tamoxifen-treated breast cancer patients?

An unusual triple-negative breast carcinoma

Suchergebnisse filtern